AbbVie Inc.ABBV

Market cap

$417.4B

P/E ratio

	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and equivalents	9,595	8,348	8,399	5,100	9,303	7,289	39,924	8,449	9,746	9,201	12,814	5,524
Short-term investments	300	26	8	1,323	486	772	-	30	84	28	2	31
Accounts receivable, net	-	-	-	-	-	5,384	5,428	8,822	9,977	11,254	11,155	10,919
Inventories	1,150	1,124	1,719	1,444	1,605	1,605	1,813	3,310	3,128	3,579	4,099	4,181
Prepaid expenses and other	1,234	1,403	1,458	3,562	4,741	1,895	2,354	3,562	4,993	4,401	4,932	4,927
Total current assets	17,848	16,088	16,314	16,187	21,223	16,945	49,519	24,173	27,928	28,463	33,002	25,582
Investments	118	92	145	1,783	2,090	1,420	93	293	277	241	304	279
Property and equipment, net	2,298	2,485	2,565	2,604	2,803	2,883	2,962	5,248	5,110	4,935	4,989	5,134
Intangible assets, net	1,890	1,513	19,709	28,897	27,559	21,233	18,649	82,876	75,951	67,439	55,610	60,068
Goodwill	6,277	5,862	13,168	15,416	15,785	15,663	15,604	33,124	32,379	32,156	32,293	34,956
Other assets	767	1,507	1,149	1,212	1,326	1,208	2,288	4,851	4,884	5,571	8,513	9,142
Total assets	29,198	27,547	53,050	66,099	70,786	59,352	89,115	150,565	146,529	138,805	134,711	135,161
Long-Term Debt and Lease Obligation, Current	18	4,021	2,025	25	6,015	1,609	3,753	8,468	12,481	4,135	7,191	6,804
Accounts payable and accrued liabilities	6,448	6,954	8,463	9,379	10,226	11,931	11,832	20,159	22,699	25,402	30,650	31,945
Total current liabilities	6,879	11,400	10,894	9,781	16,641	17,239	15,585	28,661	35,194	29,538	37,841	38,749
Long-Term Debt and Lease Obligation	14,292	10,565	29,240	36,440	30,953	35,002	62,975	77,554	64,189	59,135	52,194	60,340
Deferred income taxes	-	-	-	-	-	-	-	3,646	3,009	2,190	1,952	2,579
Other long-term liabilities	-	-	-	-	-	-	-	27,607	28,701	30,655	32,327	30,129
Common Stock, Value, Outstanding	16	16	17	18	18	18	18	18	18	18	18	18
Common stock held in treasury, at cost, 66,337,508 shares as of December 31, 2024 and 57,105,354 as of December 31, 2023	320	972	8,839	10,852	11,923	24,108	24,504	2,264	3,143	4,594	6,533	8,201
Additional paid-in capital	3,671	4,194	13,080	13,678	14,270	14,756	15,193	17,384	18,305	19,245	20,180	21,333
Accumulated deficit	1,567	535	2,248	4,378	5,459	3,368	4,717	1,055	3,127	4,784	-1,000	-7,900
Accumulated other comprehensive loss	-442	-2,031	-2,561	-2,586	-2,727	-2,480	-3,596	-3,117	-2,899	-2,199	-2,305	-1,925
Total stockholders' equity	4,492	1,742	3,945	4,636	5,097	-8,446	-8,172	13,097	15,436	17,287	10,397	3,364
Noncontrolling interest	-	-	-	-	-	-	-	21	28	33	37	39
Total equity	-	-	-	-	-	-	-	13,097	15,436	17,287	10,397	3,364
Total liabilities and equity	29,198	27,547	53,050	66,099	70,786	59,352	89,115	150,565	146,529	138,805	134,711	135,161